Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 23 matching records.
23 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Therapeutic role of caveolin family in stem cell fate and development for management of chronic degenerative diseases: A scientometric study to an in-depth review
Narrative Review on Diabetic Foot, Stroke Research, Neuroinflammation, Chronic Wound, published in J Adv Res (2026) — summary generated from the PubMed abstract.
- 2026
J Adv Res3 citations - Level BClinical TrialEurope PMC
Safety and risk management in clinical trials for chronic wounds with tissue regenerative products
Clinical Trial with a reported sample of 186 on Diabetic Foot, Chronic Wound, published in Ther Adv Drug Saf (2026) — summary generated from the PubMed abstract.
- 2026
- n = 186
Ther Adv Drug Saf - Level BRandomized Controlled TrialEurope PMC
Probiotic and Postbiotic Delivery Systems for the Management of Chronic Wounds: A Review of Emerging Strategies
Randomized Controlled Trial on Diabetic Foot, Chronic Wound, Burns, Scar, published in Cureus (2026) — summary generated from the PubMed abstract.
- 2026
Cureus - Level DNarrative ReviewPubMed
Adipose-derived stem cell exosomes: from functional mechanisms to clinical translation in diabetic foot ulcer management.
Narrative Review on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Endocrinol (Lausanne) - Level DNarrative ReviewEurope PMC
New Perspectives of Hydrogels in Chronic Wound Management
Narrative Review on Diabetic Foot, Chronic Wound, published in Molecules (2025) — summary generated from the PubMed abstract.
- 2025
Molecules31 citations - Level DNarrative ReviewEurope PMC
Understanding molecular mechanism of diabetic wound healing: addressing recent advancements in therapeutic managements
Narrative Review on Diabetic Foot, Chronic Wound, Chronic Inflammation, published in J Diabetes Metab Disord (2025) — summary generated from the PubMed abstract.
- 2025
J Diabetes Metab Disord10 citations - Level DNarrative ReviewEurope PMC
Progressive Hydrogel Applications in Diabetic Foot Ulcer Management: Phase-Dependent Healing Strategies
Narrative Review on Diabetic Foot, Chronic Wound, Chronic Inflammation, published in Polymers (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
Polymers (Basel)6 citations - Level DNarrative ReviewPubMed
Current therapeutic strategies in the management of diabetic foot ulcers.
Narrative Review on Diabetic Foot, published in Tissue Barriers (2025) — summary generated from the PubMed abstract.
- 2025
Tissue Barriers - Level BClinical TrialEurope PMC
Bioengineering Skin Substitutes for Wound Management-Perspectives and Challenges
Clinical Trial on Diabetic Foot, Chronic Wound, Burns, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci28 citations - Level DNarrative ReviewPubMed
Unveiling therapeutic potential: Adipose tissue-derived mesenchymal stem cells and their exosomes in the management of diabetes mellitus, wound healing, and chronic ulcers.
Narrative Review on Diabetic Foot, Chronic Wound, published in Biochem Pharmacol (2024) — summary generated from the PubMed abstract.
- 2024
Biochem Pharmacol - Level DNarrative ReviewEurope PMC
Research Progress of Hydrogel Microneedles in Wound Management
Narrative Review on Diabetic Foot, Chronic Wound, Scar, published in ACS Biomater Sci Eng (2024) — summary generated from the PubMed abstract.
- 2024
ACS Biomater Sci Eng26 citations - Level DNarrative ReviewEurope PMC
An Update on Diabetic Foot Ulcer and Its Management Modalities
Narrative Review on Diabetic Foot, published in Indian J Microbiol (2024) — summary generated from the PubMed abstract.
- 2024
Indian J Microbiol8 citations - Level DNarrative ReviewEurope PMC
Tissue Engineering-Based Strategies for Diabetic Foot Ulcer Management
Narrative Review on Diabetic Foot, Chronic Wound, published in Adv Wound Care (New Rochelle) (2023) — summary generated from the PubMed abstract.
- 2023
Adv Wound Care (New Rochelle)22 citations - Level DNarrative ReviewEurope PMC
Diabetic foot ulcer: A comprehensive review of pathophysiology and management modalities
Narrative Review on Diabetic Foot, published in World J Clin Cases (2023) — summary generated from the PubMed abstract.
- 2023
World J Clin Cases86 citations - Level DNarrative ReviewEurope PMC
Current status and progress in research on dressing management for diabetic foot ulcer
Narrative Review on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2023) — summary generated from the PubMed abstract.
- 2023
Front Endocrinol (Lausanne)105 citations - Level DNarrative ReviewEurope PMC
Recent Advancement of Functional Hydrogels toward Diabetic Wound Management
Narrative Review on Diabetic Foot, Chronic Wound, published in ACS Omega (2022) — summary generated from the PubMed abstract.
- 2022
ACS Omega22 citations - Level ASystematic ReviewEurope PMC
Acellular Scaffolds as Innovative Biomaterial Platforms for the Management of Diabetic Wounds
Systematic Review on Diabetic Foot, Chronic Wound, published in Tissue Eng Regen Med (2021) — summary generated from the PubMed abstract.
- 2021
Tissue Eng Regen Med11 citations - Level DNarrative ReviewEurope PMC
Injectable Hydrogels for Chronic Skin Wound Management: A Concise Review
Narrative Review on Diabetic Foot, Chronic Wound, published in Biomedicines (2021) — summary generated from the PubMed abstract.
- 2021
Biomedicines47 citations - Level DNarrative ReviewEurope PMC
Functional hydrogels for diabetic wound management
Narrative Review on Diabetic Foot, Chronic Wound, Chronic Inflammation, published in APL Bioeng (2021) — summary generated from the PubMed abstract.
- 2021
APL Bioeng99 citations - Level BRandomized Controlled TrialPubMed
Management of Diabetic Foot Ulcer with MA-ECM (Minimally Manipulated Autologous Extracellular Matrix) Using 3D Bioprinting Technology - An Innovative Approach.
Randomized Controlled Trial with a reported sample of 17 on Diabetic Foot, Chronic Wound, published in Int J Low Extrem Wounds (2021) — summary generated from the PubMed abstract.
- 2021
- n = 17
Int J Low Extrem Wounds - Level BRandomized Controlled TrialEurope PMC
Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition)
Randomized Controlled Trial on Ankle Injury, Diabetic Foot, Peripheral Artery Disease, published in Burns Trauma (2020) — summary generated from the PubMed abstract.
- 2020
Burns Trauma98 citations - Level DNarrative ReviewEurope PMC
Application of 3D Bioprinting Technologies to the Management and Treatment of Diabetic Foot Ulcers
Narrative Review on Diabetic Foot, Chronic Wound, published in Biomedicines (2020) — summary generated from the PubMed abstract.
- 2020
Biomedicines31 citations - Level DNarrative ReviewEurope PMC
Management of diabetic foot: Brief synopsis for busy orthopedist
Narrative Review on Diabetic Foot, published in J Clin Orthop Trauma (2015) — summary generated from the PubMed abstract.
- 2015
J Clin Orthop Trauma6 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406